Home β€Ί Stock analysis β€Ί PLSE

Pulse Biosciences (PLSE) Stock: Why It's Up Today

Updated Oct 20, 2026, 4:00 PM ET Β· closing price

What changed since yesterday
Compare with peers today

Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)

PLSE jumps 6.9% to $50.84. Closed at $50.84, +6.92% vs the prior close of $47.55. Day range $47.25–$52.33, opened at $47.25.

Last close$50.84+6.92%
Day range47.25–52.33
Open47.25
Volume385.90K
52-week range12.56–58.90
Avg volume (20d)455.20K

PLSE daily analysis β€” what happened

A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.

Oct 20, 2026 β€” PLSE jumps 6.9% to $50.84
Oct 19, 2026 β€” PLSE jumps 7.0% to $47.55
Oct 16, 2026 β€” PLSE dips 2.5% to $44.43, a 1-month low, 5 down days in a row
Oct 15, 2026 β€” PLSE dips 1.6% to $45.59, a 1-month low, 4 down days in a row
Oct 14, 2026 β€” PLSE slides 4.6% to $46.32, a 1-month low, 3 down days in a row
Oct 13, 2026 β€” PLSE slides 7.5% to $48.54
Oct 12, 2026 β€” PLSE dips 2.5% to $52.45
Oct 9, 2026 β€” PLSE jumps 7.7% to $53.81
Oct 8, 2026 β€” PLSE rises 1.8% to $49.98
Oct 7, 2026 β€” PLSE dips 1.3% to $49.09
Oct 6, 2026 β€” PLSE dips 1.5% to $49.75
Oct 5, 2026 β€” PLSE jumps 5.4% to $50.50
Oct 2, 2026 β€” PLSE slides 3.9% to $47.90, a 1-month low, 4 down days in a row

PLSE bull case vs bear case (from the data)

Bull case
  • Price is +1.9% vs its 50-day average β€” short-term trend is up.
  • Price is +70.5% vs its 200-day average β€” above the long-term trend line.
  • Insiders made 25 open-market purchases in the last 12 months.
Bear case
  • Latest fiscal-year net income: loss of $72.78M.
  • Share count up 6.0% in a year (dilution).
  • High volatility: average daily move of 3.1% over 20 sessions.

PLSE latest news & SEC filings

Every SEC filing by or about PLSE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 14, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-032601

Oct 7, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-032271

Sep 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-030456

Sep 15, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001437749-26-030455

Sep 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-030392

Sep 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001437749-26-029545

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001437749-26-029233

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-029231

Aug 28, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001437749-26-029229

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001437749-26-029220

Aug 28, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001437749-26-029215

Aug 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001437749-26-026351

Aug 6, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001437749-26-026350

Aug 6, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001437749-26-026288

Aug 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001437749-26-026256

Things to know before you trade PLSE

PLSE market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 20, 202647.2552.3347.2550.84385.90K
Oct 19, 202644.5848.1244.5847.55342.50K
Oct 16, 202645.4946.6743.3244.43327.40K
Oct 15, 202645.1346.6743.9645.59425.60K
Oct 14, 202647.6048.9744.8046.32440.30K
Oct 13, 202653.0253.2148.0148.54455.50K
Oct 12, 202653.5353.9850.1552.45434.40K
Oct 9, 202649.9853.9749.9853.81365.80K
Oct 8, 202648.9050.3247.3149.98315.60K
Oct 7, 202649.1149.9348.1349.09409.50K
Oct 6, 202651.2651.2648.6249.75421.40K
Oct 5, 202647.8950.9947.4750.50433.40K
Oct 2, 202650.1350.7147.7547.90519.10K
Oct 1, 202649.4951.5649.1249.83450.30K
Sep 30, 202651.1851.2749.1749.92604.60K
Sep 29, 202652.2452.7448.9250.89516.90K
Sep 28, 202651.6353.6051.1452.32374.40K
Sep 25, 202652.1754.0550.8051.63664.00K
Sep 24, 202652.1853.6051.6251.83666.90K
Sep 23, 202653.7556.7451.8751.98550.60K

About Pulse Biosciences

Pulse Biosciences (PLSE) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in HAYWARD, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1625101.

PLSE board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Robert W DugganDirectorJun 15, 2026
Paul A LavioletteChief Executive OfficerMay 11, 2026
Maria SainzDirectorJun 15, 2026
Manmeet Singh SoniDirectorJun 15, 2026
Darrin UeckerChief Technology OfficerApr 3, 2026
Mahkam ZanganehDirectorJun 15, 2026
Den Broek Richard VanDirectorJun 15, 2026

Executive officers

NameTitleLatest filing
Kevin Patrick DanahyChief Commercial OfficerFeb 23, 2026
Paul A LavioletteChief Executive OfficerMay 11, 2026
Jon SkinnerChief Financial OfficerAug 28, 2026
Liane Rae TeplitskyChief Operating OfficerSep 2, 2026
Darrin UeckerChief Technology OfficerApr 3, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 1, 2026Liane Rae TeplitskyBuy1,001$49.95
Sep 1, 2026Liane Rae TeplitskyBuy1,001$49.95
Sep 1, 2026Liane Rae TeplitskyBuy1,001$49.95
Sep 1, 2026Liane Rae TeplitskyBuy1,001$49.95
Aug 31, 2026Liane Rae TeplitskyBuy1,024$48.80
Aug 31, 2026Liane Rae TeplitskyBuy1,024$48.80
Aug 31, 2026Liane Rae TeplitskyBuy1,024$48.80
Aug 31, 2026Liane Rae TeplitskyBuy1,024$48.80
Aug 28, 2026Liane Rae TeplitskyBuy1,034$48.35
Aug 28, 2026Liane Rae TeplitskyBuy1,034$48.35
Aug 28, 2026Liane Rae TeplitskyBuy1,034$48.35
Aug 28, 2026Liane Rae TeplitskyBuy1,034$48.35
Aug 26, 2026Liane Rae TeplitskyBuy1,036$48.24
Aug 26, 2026Liane Rae TeplitskyBuy1,036$48.24
Aug 26, 2026Liane Rae TeplitskyBuy1,036$48.24

PLSE financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$350.00K$-72.78M-1.08$-54.12M
Dec 31, 2024$0$-53.59M-0.92$-36.34M
Dec 31, 2023$0$-42.21M-0.85$-33.04M
Dec 31, 2022$700.00K$-58.51M-1.72$-47.01M
Dec 31, 2021$1.42M$-63.66M-2.28$-54.10M

Latest balance sheet: total assets $115.56M, total liabilities $16.06M, cash $101.62M (as of Jun 30, 2026).

PLSE earnings / results-day log

DateFilingClose that day
Aug 6, 20268-K Item 2.02 (results)$38.24
May 4, 20268-K Item 2.02 (results)$20.03
Feb 19, 20268-K Item 2.02 (results)$25.08
Nov 5, 20258-K Item 2.02 (results)$16.27
Aug 12, 20258-K Item 2.02 (results)$15.10
May 8, 20258-K Item 2.02 (results)$16.85
Mar 28, 20258-K Item 2.02 (results)$16.60
Oct 30, 20248-K Item 2.02 (results)$17.72
Aug 12, 20248-K Item 2.02 (results)β€”
Jul 15, 20248-K Item 2.02 (results)β€”
May 7, 20248-K Item 2.02 (results)β€”
Mar 28, 20248-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Dexcom (DXCM)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)

More on PLSE

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.